| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
| mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-05 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-05 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |